IL6 and COVID-19: The clinical worsening of individuals with COVID-19 may be related to immunopathological damage, reflected by increased concentrations of proinflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6) (45).